Memsorb Filter System for Anesthesia Environmental Impact
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for managing carbon dioxide during surgery using a device called Memsorb. Memsorb reduces anesthesia waste and lowers pollution by filtering out carbon dioxide without producing harmful byproducts. The trial compares Memsorb to traditional methods across various surgeries to evaluate its effectiveness. Individuals scheduled for planned, non-emergency surgeries without severe breathing issues may qualify for participation. As an unphased trial, this study allows participants to contribute to innovative research that could lead to more environmentally friendly surgical practices.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Memsorb Filter System is safe for use in anesthesia?
Research has shown that the Memsorb system safely removes CO2 from anesthesia machines without harmful chemicals, avoiding toxic byproducts that some traditional methods produce. The Memsorb employs a special filter, similar to those in heart surgery, to remove CO2 while retaining the anesthetic gas. This approach aims to reduce the amount of anesthetic needed, potentially benefiting both patients and the environment.
In contrast, chemical granulate absorbers (CGAs) currently in use can react with anesthetic gases to create toxic byproducts, which may harm the kidneys and nervous system. Increasing anesthetic gas to dilute these byproducts also raises costs and environmental impact.
Although specific safety studies on Memsorb in humans are not yet available, the technology resembles other safe methods. Its goal to eliminate harmful chemical reactions suggests it could be a safer option. However, always consider joining a clinical trial after consulting healthcare professionals for personalized advice.12345Why are researchers excited about this trial?
Researchers are excited about the Memsorb Filter System because it offers a way to make anesthesia more environmentally friendly. Unlike traditional chemical CO2 absorbers, Memsorb doesn't rely on chemicals to filter out CO2, which can reduce the environmental impact of anesthesia practices. This new approach could help hospitals lower their carbon footprint without altering existing anesthesia settings, making it a promising alternative to current methods.
What evidence suggests that the Memsorb Filter System is effective for reducing anesthesia environmental impact?
Research has shown that the Memsorb filter system, one of the treatments studied in this trial, effectively removes carbon dioxide (CO2) from anesthesia equipment without using chemical granulate absorbers (CGAs), which are tested in separate trial arms. This means Memsorb avoids creating potentially harmful byproducts that CGAs might produce. Studies have found that Memsorb can reduce the use of anesthetic gases by up to 20%. This not only saves money but also lessens environmental impact since fewer gases are released into the air. Memsorb uses a special membrane technology, similar to that used in heart surgeries, to filter out CO2 while keeping the anesthetic gas in the system. The filter is designed to last at least a year, potentially reducing waste and lowering costs for hospitals.678910
Are You a Good Fit for This Trial?
This trial is for patients undergoing elective surgery, specifically laparoscopic for one part of the study. They should have a physical status classification of ASA I to III, meaning they range from healthy to having some severe disease but not incapacitated. It's not for those with high intracranial pressure, very severe systemic disease (ASA > IV), emergencies, severe respiratory issues like asthma, pregnant individuals or surgeries using regional anesthesia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo general anesthesia using either Memsorb or CGA systems during various surgical procedures
Follow-up
Participants are monitored for safety and effectiveness after anesthesia
What Are the Treatments Tested in This Trial?
Interventions
- Chemical granulate absorber
- Memsorb
Find a Clinic Near You
Who Is Running the Clinical Trial?
Western University, Canada
Lead Sponsor